News Sentiment

NAGE sentiment intelligence

Niagen Bioscience, Inc. news scored across direct company coverage, industry context, sector read-through, source quality, and freshness.

Chart Weekly report Factors RSS feed
Weighted score 55 Balanced news tone 64 relevant articles
Exchange NASDAQ United States
Sector Healthcare Market context
Industry Biotechnology Read-through group
Latest close 3.28 Week of 17 Jul 2026
Weighted tone 55/100

Balanced news tone

Market reaction Balanced read

News tone and price action are not far from neutral.

Primary event Market update

81/100 classification confidence.

Company focus 55

directly relevant articles

Source quality 1

high-authority source matches

Trend context Trend inactive

-3.2% over one week, -6.3% over four weeks, trend inactive, and below fair value.

Latest direct headline Neutral

Niagen Bioscience (NAGE) to Announce Q2 Financial Results on August 4, 2026

Market Reaction

Balanced read

64/100 confidence

News tone and price action are not far from neutral.

Primary event Market update 81/100 classification
One-week reaction -3.2% Price reacting lower
Trend fit Trend inactive -6.3% over four weeks
Fair value -34.2% Below fair value
Value support

Sentiment Mix

Positive, neutral, negative

Weighted by relevance
Positive 15
Neutral 44
Negative 5

Relevance

Why the article matched

Direct first
Direct company coverage 55
Industry context 9
Sector context 0

Sources

Coverage mix

Publishers
Market source 15
Stock Titan 10
Business Wire 7
simplywall.st 6
Investing.com 3
Investing.com Canada 3
TradingView 3
scanx.trade 2

Event Lens

What the news is about

Classified themes
Market update 36
Earnings 20
Analyst action 5
Guidance 2
Capital return 1

Sentiment Trail

Score over time

50 baseline
Above 50 Neutral zone Below 50

News Tape

Relevant headlines

Showing 31-60 of 64
Investing.com Nigeria Direct company coverage

Form S-3 Niagen Bioscience Inc For: 29 June By Investing.com

This article announces that Investing.com has published information regarding the Form S-3 filing by Niagen Bioscience Inc for June 29. The brief notice highlights the filing and its publication date. It also provides current stock market data for various indices, commodities, an

Tone
Neutral 50/100
Event
Market update
Published
30 Jun 2026 03:40
Source
Investing.com Nigeria
Investing.com Australia Direct company coverage

Form 4 Niagen Bioscience Inc For: 26 June By Investing.com

This article provides an Investing.com report on the Form 4 filing for Niagen Bioscience Inc., dated June 26. It includes standard disclaimers about the high risks associated with trading financial instruments and cryptocurrencies, emphasizing that the provided data may not be re

Tone
Neutral 50/100
Event
Market update
Published
27 Jun 2026 01:39
Source
Investing.com Australia
Stock Titan Direct company coverage

Niagen Bioscience (NAGE) director granted 31,746 stock options at $3.45

Niagen Bioscience (NAGE) director Patrick Kristin was granted 31,746 stock options with an exercise price of $3.45 per share. These options will vest 100% on June 24, 2027, and have an expiration date of June 23, 2036. This transaction is classified as an equity compensation awar

Tone
Neutral 50/100
Event
Market update
Published
26 Jun 2026 22:10
Source
Stock Titan